AccScience Publishing / JCTR / Online First / DOI: 10.36922/JCTR026090014
REVIEW ARTICLE

A pandemic within a pandemic: Diabetes, gestational diabetes, and vitamin B12 deficiency in pregnant women during the COVID-19 era

Huseyin Karakaya1 Meral Ekim2 Hasan Ekim3 Gokhan Dogukan Akarsu4*
Show Less
1 Department of Gynecology and Obstetrics, Faculty of Medicine, Yozgat Bozok University, Yozgat, Türkiye
2 Department of Biochemistry, Faculty of Medicine, Yozgat Bozok University, Yozgat, Türkiye
3 3 Department of Cardiovascular Surgery, Faculty of Medicine, Yozgat Bozok University, Yozgat, Türkiye
4 Department of Pharmacy Services, Vocational School of Health Services, Yozgat Bozok University, Yozgat, Türkiye
Received: 23 February 2026 | Revised: 30 April 2026 | Accepted: 8 May 2026 | Published online: 16 June 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly worsened health outcomes in pregnant women, a population already vulnerable due to physiological immune suppression and increased insulin resistance. Gestational diabetes mellitus (GDM) and vitamin B12 deficiency further compound these risks, creating a complex and potentially dangerous clinical picture. Aim: This review examines the interrelationships between COVID-19, GDM, and vitamin B12 deficiency in pregnancy, and evaluates the clinical implications for maternal and fetal health. Methods: A narrative review of the current literature was conducted, focusing on the mechanisms linking severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, GDM, vitamin B12 metabolism, metformin use, and nutritional status during pregnancy. Results: SARS-CoV-2 directly damages pancreatic beta cells and triggers hyperinflammation, disrupting glycemic control in pregnant women. Vitamin B12 deficiency elevates homocysteine levels, impairing insulin signaling and promoting thrombosis, thereby increasing risks of GDM, preeclampsia, and adverse fetal neurodevelopmental outcomes. Metformin, widely used in GDM and polycystic ovary syndrome (PCOS) management, further reduces B12 absorption. Pandemic-related disruptions to antenatal care, food access, and psychosocial stress accelerated B12 depletion in this population. The Mediterranean diet offers partial mitigation, though targeted supplementation remains necessary in high-risk individuals. Conclusion: Routine B12 screening should be integrated into standard antenatal care, particularly for women with GDM, PCOS, or long-term metformin use. Relevance for patients: Pregnant women with GDM or PCOS using metformin are at heightened risk of vitamin B12 deficiency, which can silently harm both mother and baby. Regular B12 monitoring and timely supplementation are simple, safe, and potentially life-changing interventions.

Graphical abstract
Keywords
COVID-19
Gestational diabetes
Vitamin B12 deficiency
Pregnancy
Metformin
Mediterranean diet
Homocysteine
SARS-CoV-2
Funding
None.
Conflict of interest
The authors declare they have no competing interests.
References
  1. Sharma A, Misra-Hebert AD, Mariam A, et al. Impacts of COVID-19 on glycemia and risk of diabetic ketoacidosis. Diabetes. 2023;72(5):627-637. doi: 10.2337/db22-0264
  2. Abbas RH, Thaker AA, Ali HH. Relationship between vitamin B12, homocysteine, and immunological parameters in patients with type 2 diabetes. J Pharm Negative Results. 2022;13(S01):689-693. doi: 10.47750/pnr.2022.13.s01.85
  3. Bouhanick B, Cracowski JL, Faillie JL; French Society of Pharmacology, Therapeutics (SFPT). Diabetes and COVID- 19. Therapie. 2020;75(4):327-333. doi: 10.1016/j.therap.2020.05.006
  4. Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. 2022;65(6):949-954. doi: 10.1007/s00125-022-05670-0
  5. Georgoulis M, Kontogianni MD, Yiannakouris N. Mediterranean diet and diabetes: prevention and treatment. Nutrients. 2014;6(4):1406-1423. doi: 10.3390/nu6041406
  6. American Diabetes Association. Standards of medical care in diabetes—2017. Diabetes Care. 2017;40(suppl 1):S1-S2. doi: 10.2337/dc17-S001
  7. Finer S, Saravanan P, Hitman G, Yajnik C. The role of the one-carbon cycle in the developmental origins of type 2 diabetes and obesity. Diabet Med. 2014;31(3):263-272. doi: 10.1111/dme.12390
  8. Zalaket J, Wehbe T, Abou Jaoude E. Vitamin B12 deficiency in diabetic subjects taking metformin: a cross sectional study in a Lebanese cohort. J Nutr Intermed Metab. 2018;11:9-13. doi: 10.1016/j.jnim.2017.12.001
  9. Khattab R, Albannawi M, Alhajjmohammed D, et al. Metformin-induced vitamin B12 deficiency among type 2 diabetes mellitus patients: a systematic review. Curr Diabetes Rev. 2023;19(4):e160922209008. doi: 10.2174/1573399818666220418080959
  10. Gul A, Siddiqi FA, Amir M, Arshad AR, Qayyum S, Shakireen N. Vitamin B12 deficiency in relation to metformin use in adults with type-2 diabetes mellitus. Life Sci. 2023;4(2):4. doi: 10.37185/lns.1.1.271
  11. Sayedali E, Yalin AE, Yalin S. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes. World J Diabetes. 2023;14(5):585-593. doi: 10.4239/wjd.v14.i5.585
  12. Eskin F, Tutan D. Is there a relationship between metformin-related gastrointestinal symptoms and vitamin B12 deficiency in patients with type 2 diabetes mellitus? Med Sci. 2023;12(1):324. doi: 10.5455/medscience.2022.11.338
  13. Satapathy S, Bandyopadhyay D, Patro BK, Khan S, Naik S. Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: a multi-arm randomized controlled clinical trial. Complement Ther Med. 2020;53:102526. doi: 10.1016/j.ctim.2020.102526
  14. Kouroglou E, Anagnostis P, Daponte A, Bargiota A. Vitamin B12 insufficiency is associated with increased risk of gestational diabetes mellitus: a systematic review and meta-analysis. Endocrine. 2019;66(2):149-156. doi: 10.1007/s12020-019-02053-1
  15. Sukumar N, Venkataraman H, Wilson S, et al. Vitamin B12 status among pregnant women in the UK and its association with obesity and gestational diabetes. Nutrients. 2016;8(12):768. doi: 10.3390/nu8120768
  16. Ashiq S, Shabana. Vitamin B12 deficiency in type I diabetes. J Microbiol Mol Genet. 2020;1(2):44-49. doi: 10.52700/jmmg.v1i2.19
  17. Sezgin Y, Becel S. Evaluation of lipid parameters in patients receiving vitamin B12 therapy. Istanbul Med J. 2019;20(3):214-217. doi: 10.4274/imj.galenos.2019.37974
  18. Karatas S, Yesim T, Beysel S. Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people. Prim Care Diabetes. 2021;15(3):424-427. doi: 10.1016/j.pcd.2021.01.003
  19. Maiorino MI, Bellastella G, Longo M, Caruso P, Esposito K. Mediterranean diet and COVID-19: hypothesizing potential benefits in people with diabetes. Front Endocrinol. 2020;11:574315. doi: 10.3389/fendo.2020.574315
  20. Wu C, Zheng M, Yang Y, et al. Furin: a potential therapeutic target for COVID-19. iScience. 2020;23(10):101642. doi: 10.1016/j.isci.2020.101642
  21. Ou X, Liu Y, Lei X, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11(1):1620. doi: 10.1038/s41467-020-15562-9
  22. Alsaadi EAJ, Jones IM. Membrane binding proteins of coronaviruses. Future Virol. 2019;14(4):275-286. doi: 10.2217/fvl-2018-0144
  23. Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355-362. doi: 10.1038/s41577-020-0331-4
  24. dos Santos LMJ. Can vitamin B12 be an adjuvant to COVID- 19 treatment? GSC Biol Pharm Sci. 2020;11(3):001-005. doi: 10.30574/gscbps.2020.11.3.0155
  25. Pandya M, Shah S, Dhanalakshmi M, et al. Unravelling vitamin B12 as a potential inhibitor against SARS-CoV-2: a computational approach. Inform Med Unlocked. 2022;30:100951. doi: 10.1016/j.imu.2022.100951
  26. Troen AM. Folate and vitamin B12: function and importance in cognitive development. In: Nestle Nutr Inst Workshop Ser. S. Karger AG; 2012;70:161-171. doi: 10.1159/000337684
  27. Kennedy DO. B vitamins and the brain: mechanisms, dose and efficacy—a review. Nutrients. 2016;8(2):68. doi: 10.3390/nu8020068
  28. Ulusal Diyabet Konsensus Grubu. Diyabet Tanı ve Tedavi Rehberi 2021 [in Turkish]. Türkiye Diyabet Vakfı; 2021. Available from: https://www.turkdiab.org/admin/PICS/ webfiles/Diyabet_Tani_ve_Tedavi_Rehberi_2021.pdf [Last accessed on April 30, 2026].
  29. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract. 2010;87(1):15-19. doi: 10.1016/j.diabres.2009.10.006
  30. Emerging Risk Factors Collaboration; Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829- 841. doi: 10.1056/NEJMoa1008862
  31. Stasi C, Fallani S, Voller F, Silvestri C. Treatment for COVID- 19: an overview. Eur J Pharmacol. 2020;889:173644. doi: 10.1016/j.ejphar.2020.173644
  32. Rezaee H, Pourkarim F, Pourtaghi-Anvarian S, et al. Drug-drug interactions with candidate medications used for COVID-19 treatment: an overview. Pharmacol Res Perspect. 2021;9(1):e00705. doi: 10.1002/prp2.705
  33. Gil C, Ginex T, Maestro I, et al. COVID-19: drug targets and potential treatments. J Med Chem. 2020;63(21):12359- 12386. doi: 10.1021/acs.jmedchem.0c00606
  34. Ramakrishnan M, Poojari PG, Rashid M, et al. Impact of COVID-19 pandemic on medicine supply chain for patients with chronic diseases: experiences of the community pharmacists. Clin Epidemiol Glob Health. 2023;20:101243. doi: 10.1016/j.cegh.2023.101243
  35. Clement J, Jacobi M, Greenwood BN. Patient access to chronic medications during the Covid-19 pandemic: evidence from a comprehensive dataset of US insurance claims. PLoS ONE. 2021;16(4):e0249453. doi: 10.1371/journal.pone.0249453
  36. Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID- 19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877
  37. Freise NF, Kivel M, Grebe O, et al. Acute cardiac side effects after COVID-19 mRNA vaccination: a case series. Eur J Med Res. 2022;27(1):80. doi: 10.1186/s40001-022-00695-y
  38. Badell ML, Dude CM, Rasmussen SA, Jamieson DJ. Covid- 19 vaccination in pregnancy. BMJ. 2022;378:e069741. doi: 10.1136/bmj-2021-069741
  39. Khan F, Khan MT, Zaman S, et al. Side effects of COVID-19 vaccines among diabetic subjects and healthy individuals. Cureus. 2023;15(3):e36005. doi: 10.7759/cureus.36005
  40. Gubbi S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, Pacak K. Catecholamine physiology and its implications in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(12):978-986. doi: 10.1016/s2213-8587(20)30342-9
  41. Guarnotta V, Ferrigno R, Martino M, et al. Glucocorticoid excess and COVID-19 disease. Rev Endocr Metab Disord. 2020;22(4):703-714. doi: 10.1007/s11154-020-09598-x
  42. Specktor P, Hadar D, Cohen H. Glucocorticoid treatment during COVID-19 infection: does it affect the incidence of long COVID? Inflammopharmacology. 2024;32(6):3707- 3715. doi: 10.1007/s10787-024-01576-y
  43. Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract. 2020;162:108118. doi: 10.1016/j.diabres.2020.108118
  44. Mahrooz A, Muscogiuri G, Buzzetti R, Maddaloni E. The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism. Endocrine. 2021;72(2):317-325. doi: 10.1007/s12020-021-02729-7
  45. Hasan SS, Kow CS, Bain A, Kavanagh S, Merchant HA, Hadi MA. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2020;22(2):229-240. doi: 10.1080/14656566.2020.1837114
  46. Xie L, Zhang Z, Wang Q, Chen Y, Lu D, Wu W. COVID- 19 and diabetes: a comprehensive review of angiotensin converting enzyme 2, mutual effects and pharmacotherapy. Front Endocrinol. 2021;12:772865. doi: 10.3389/fendo.2021.772865
  47. Mahluji S, Jalili M, Ostadrahimi A, Hallajzadeh J, Ebrahimzadeh-Attari V, Saghafi-Asl M. Nutritional management of diabetes mellitus during the pandemic of COVID-19: a comprehensive narrative review. J Diabetes Metab Disord. 2021;20(1):963-972. doi: 10.1007/s40200-021-00784-5
  48. Pettus J, Skolnik N. Importance of diabetes management during the COVID-19 pandemic. Postgrad Med. 2021;133(8):912-919. doi: 10.1080/00325481.2021.1978704
  49. Aslaner H, İnanç N, Gökçek MB, et al. The effect of vitamin B12 levels on prognosis in COVID-19 patients. J Contemp Med. 2022;12(2):359-363. doi: 10.16899/jcm.1035078
  50. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID- 19 syndrome. Nat Med. 2021;27(4):601-615. doi: 10.1038/s41591-021-01283-z
  51. Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID- 19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013-1022. doi: 10.1002/jmv.26368
  52. Manzanares W, Hardy G. Farmaconutrición de la vitamina B12 para COVID-19 [in Spanish]. Rev Nutr Clínica y Metab. 2020;4(1):65-69.. doi: 10.35454/rncm.v4n1.187
  53. Lymperaki E, Kazeli K, Variti G, et al. Potential role of certain biomarkers such as vitamin B12, ROS, albumin, as early predictors for prognosis of COVID-19 outcomes. Medicines. 2022;9(6):36. doi: 10.3390/medicines9060036
  54. Rayman G, Lumb A, Kennon B, et al. Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes. Diabet Med. 2021;38(1):e14378. doi: 10.1111/dme.14378
  55. Younes YR, Stockley S, Keegan L, et al. COVID-19 and dexamethasone-induced hyperglycaemia: workload implications for diabetes inpatient teams. Diabet Med. 2022;39(2):e14716. doi: 10.1111/dme.14716
  56. Singh AK, Majumdar S, Singh R, Misra A. Role of corticosteroid in the management of COVID-19: a systemic review and a clinician’s perspective. Diabetes Metab Syndr. 2020;14(5):971-978. doi: 10.1016/j.dsx.2020.06.054
  57. Unnikrishnan R, Misra A. Diabetes and COVID-19: a bidirectional relationship. Nutr Diabetes. 2021;11(1):21. doi: 10.1038/s41387-021-00163-2
  58. Harding JL, Oviedo SA, Ali MK, et al. The bidirectional association between diabetes and long-COVID-19: a systematic review. Diabetes Res Clin Pract. 2023;195:110202. doi: 10.1016/j.diabres.2022.110202
  59. Hayden MR. An immediate and long-term complication of COVID-19 may be type 2 diabetes mellitus: the central role of β-cell dysfunction, apoptosis and exploration of possible mechanisms. Cells. 2020;9(11):2475. doi: 10.3390/cells9112475
  60. Kanzy A, Madkhali M, Imam S, Jaume J. Development of latent autoimmune diabetes of adults post SARS-CoV-2 mRNA vaccination. Diabetes Res Clin Pract. 2022;186:109369. doi: 10.1016/j.diabres.2022.109369
  61. Lu JY, Wilson J, Hou W, et al. Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza. eBioMedicine. 2023;90:487. doi: 10.1016/j.ebiom.2023.104487
  62. Rai S, Rai BS, Pakkala PR. The potential role of vitamin B12 in the prevention of COVID-19 complications: a narrative review. J Pure Appl Microbiol. 2021;15(4):1735-1744. doi: 10.22207/jpam.15.4.04
  63. Wee AKH. COVID-19’s toll on the elderly and those with diabetes mellitus—is vitamin B12 deficiency an accomplice? Med Hypotheses. 2021;146:110374. doi: 10.1016/j.mehy.2020.110374
  64. Erkurt MA, Aydogdu I, Dikilitaş M, et al. Effects of cyanocobalamin on immunity in patients with pernicious anemia. Med Princ Pract. 2008;17(2):131-135. doi: 10.1159/000112967
  65. Jayawardena R, Jeyakumar DT, Francis TV, Misra A. Impact of the vitamin D deficiency on COVID-19 infection and mortality in Asian countries. Diabetes Metab Syndr. 2021;15(3):757-764. doi: 10.1016/j.dsx.2021.03.006
  66. Li W, Zhao J, Zhu LL, Peng YF. Serum vitamin B12 levels and glycemic fluctuation in patients with type 2 diabetes mellitus. Ther Adv Endocrinol Metab. 2022;13:20420188221102800. doi: 10.1177/20420188221102800
  67. Yousef Khan F, Yousif AB, Suliman A, et al. Association of vitamin B12 deficiency with metformin use in patients with type 2 diabetes treated in the largest tertiary care hospital in Qatar. Qatar Med J. 2021;2021(2):39. doi: 10.5339/qmj.2021.39
  68. Wulffele MG, Kooy A, Lehert P, et al. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med. 2003;254(5):455-463. doi: 10.1046/j.1365-2796.2003.01213.x
  69. de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010;340(may19 4):c2181. doi: 10.1136/bmj.c2181
  70. Yang W, Cai X, Wu H, Ji L. Associations between metformin use and vitamin B12 levels, anemia, and neuropathy in patients with diabetes: a meta-analysis. J Diabetes. 2019;11(9):729-743. doi: 10.1111/1753-0407.12900
  71. Kos E, Liszek MJ, Emanuele MA, Durazo-Arvizu R, Camacho P. Effect of metformin therapy on vitamin D and vitamin B12 levels in patients with type 2 diabetes mellitus. Endocr Pract. 2012;18(2):179-184. doi: 10.4158/EP11009.OR
  72. Chapman LE, Darling AL, Brown JE. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab. 2016;42(5):316-327. doi: 10.1016/j.diabet.2016.03.008
  73. Wile DJ, Toth C. Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care. 2010;33(1):156-161. doi: 10.2337/dc09-0606
  74. Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761. doi: 10.1210/jc.2015-3754
  75. Ko SH, Ko SH, Ahn YB, et al. Association of vitamin B12 deficiency and metformin use in patients with type 2 diabetes. J Korean Med Sci. 2014;29(7):965. doi: 10.3346/jkms.2014.29.7.965
  76. Ahmed MA, Muntingh G, Rheeder P. Vitamin B12 deficiency in metformin-treated type-2 diabetes patients, prevalence and association with peripheral neuropathy. BMC Pharmacol Toxicol. 2016;17(1):44. doi: 10.1186/s40360-016-0088-3
  77. Bell DS. Metformin-induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes. Diabetes Obes Metab. 2022;24(8):1423-1428. doi: 10.1111/dom.14734
  78. Ruscin JM, Page RL 2nd, Valuck RJ. Vitamin B12 deficiency associated with histamine2-receptor antagonists and a proton-pump inhibitor. Ann Pharmacother. 2002;36(5):812- 816. doi: 10.1345/aph.10325
  79. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. US Department of Health and Human Services; 2011. Accessed on April 30, 2026. https://stacks.cdc.gov/ view/cdc/13329
  80. Khalaf KM, Khudhair MS, Ashor AW. Vitamin B12 status and peripheral neuropathy in patients with type 2 diabetes mellitus. JPMA J Pak Med Assoc. 2019;69(suppl 3)(8):S40- S44.
  81. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP Jr. Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements. Diabetes Care. 2012;35(2):327-333. doi: 10.2337/dc11-1582
  82. Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Seaquist D, Topolski R. The prevalence of vitamin B12 deficiency in patients with type 2 diabetes: a cross-sectional study. J Am Board Fam Med. 2009;22(5):528-534. doi: 10.3122/jabfm.2009.05.090044
  83. Adaikalakoteswari A, Jayashri R, Sukumar N, et al. Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes. Cardiovasc Diabetol. 2014;13(1):129. doi: 10.1186/s12933-014-0129-4
  84. Sashindran VK, Aggarwal V, Khera A. Prevalence of vitamin B12 deficiency in elderly population (>60 years) presenting with dementia to outpatient department. Med J Armed Forces India. 2022;78(1):94-98. doi: 10.1016/j.mjafi.2020.11.003
  85. Elsayed AM, Ibrahim WM, Magdi MA, Elbadawy A. Prevalence of vitamin B12 deficiency among diabetic patients in Benha City, Egypt, a hospital based: a cross-section study. Benha Med J. 2022;39(2):334-345. doi: 10.21608/bmfj.2021.94243.1475
  86. Baig FA, Khan S, Rizwan A. Frequency of vitamin B12 deficiency in type 2 diabetic patients taking metformin. Cureus. 2022;14(3):e22924. doi: 10.7759/cureus.22924
  87. Dror DK, Allen LH. Interventions with vitamins B6, B12 and C in pregnancy. Paediatr Perinat Epidemiol. 2012;26(suppl 1):55-74. doi: 10.1111/j.1365-3016.2012.01277.x
  88. Kırat S. The importance of micronutrient deficiency in the etiology of anemia in the first trimester of pregnancy: a cross-sectional study. Kafkas J Med Sci. 2024;14(3):304-310. doi: 10.5505/kjms.2024.73478
  89. Myilsamy S, Kandasamy S, Vijayakumar P, Periaswamy P. A cross-sectional study of serum B12 and folate level in alcoholics and nonalcoholics. Muller J Med Sci Res. 2022;13(1):18-21. doi: 10.4103/mjmsr.mjmsr_10_22
  90. Vogiatzoglou A, Smith AD, Nurk E, et al. Dietary sources of vitamin B-12 and their association with plasma vitamin B-12 concentrations in the general population: the Hordaland Homocysteine Study. Am J Clin Nutr. 2009;89(4):1078-1087. doi: 10.3945/ajcn.2008.26598
  91. Jung SB, Nagaraja V, Kapur A, Eslick GD. Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systematic review and meta-analysis. Intern Med J. 2015;45(4):409-416. doi: 10.1111/imj.12697
  92. Linnebank M, Moskau S, Semmler A, et al. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol. 2011;69(2):352-359. doi: 10.1002/ana.22229
  93. Margalit I, Cohen E, Goldberg E, Krause I. Vitamin B12 deficiency and the role of gender: a cross-sectional study of a large cohort. Ann Nutr Metab. 2018;72(4):265-271. doi: 10.1159/000488326
  94. Cohen E, Margalit I, Shochat T, Goldberg E, Krause I. Gender differences in homocysteine concentrations, a population-based cross-sectional study. Nutr Metab Cardiovasc Dis. 2019;29(1):9-14. doi: 10.1016/j.numecd.2018.09.003
  95. Schwahn BC, Chen Z, Laryea MD, et al. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J. 2003;17(3):1-25. doi: 10.1096/fj.02-0456fje
  96. Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology. 2003;2003(1):62-81. doi: 10.1182/asheducation-2003.1.62
  97. Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut. 1994;35(1):23-26. doi: 10.1136/gut.35.1.23
  98. Aydin B, Cansu GB, Ozlu C. Relationship between glycosylated hemoglobin and vitamin B12 deficiency anemia. North Clin Istanb. 2022;9(5):459-463. doi: 10.14744/nci.2022.76259
  99. Beck MA, Handy J, Levander OA. Host nutritional status: the neglected virulence factor. Trends Microbiol. 2004;12(9):417- 423. doi: 10.1016/j.tim.2004.07.007
  100. Angelidi AM, Kokkinos A, Katechaki E, Ros E, Mantzoros CS. Mediterranean diet as a nutritional approach for COVID-19. Metabolism. 2021;114:154407. doi: 10.1016/j.metabol.2020.154407
  101. Demirer B, Yardımcı H, Basmaz SE. Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: a pathway analysis. J Diabetes Complications. 2023;37(1):108354. doi: 10.1016/j.jdiacomp.2022.108354
  102. Perez-Araluce R, Martinez-Gonzalez MA, Fernández-Lázaro CI, Bes-Rastrollo M, Gea A, Carlos S. Mediterranean diet and the risk of COVID-19 in the ‘Seguimiento Universidad de Navarra’ cohort. Clin Nutr. 2022;41(12):3061-3068. doi: 10.1016/j.clnu.2021.04.001
  103. Hirabara SM, Gorjao R, Curi R, Leandro CG, Marzuca- Nassr GN. Nutritional modulation of inflammation and insulin resistance. Front Nutr. 2023;10:1181809. doi: 10.3389/fnut.2023.1181809
  104. Bousquet J, Anto JM, Iaccarino G, et al. Is diet partly responsible for differences in COVID-19 death rates between and within countries? Clin Transl Allergy. 2020;10(1). doi: 10.1186/s13601-020-00323-0
  105. Domínguez-López I, Arancibia-Riveros C, Marhuenda- Muñoz M, et al. Association of microbiota polyphenols with cardiovascular health in the context of a Mediterranean diet. Food Res Int. 2023;165:112499. doi: 10.1016/j.foodres.2023.112499
  106. Iddir M, Brito A, Dingeo G, et al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 2020;12(6):1562. doi: 10.3390/nu12061562
  107. Dashraath P, Wong JLJ, Lim MXK, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020;222(6):521-531. doi: 10.1016/j.ajog.2020.03.021
  108. Allotey J, Fernandez S, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320
  109. Metz TD, Clifton RG, Hughes BL, et al. Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA. 2022;327(8):748. doi: 10.1001/jama.2022.1190
  110. Sweeting A, Wong J, Murphy HR, Ross GP. A clinical update on gestational diabetes mellitus. Endocr Rev. 2022;43(5):763- 793. doi: 10.1210/endrev/bnac003
  111. Khalil EM, Madney YM, Hassan M, et al. Maternal and fetal outcome of COVID-19 infection among pregnant women. Medicina. 2024;60(10):1676. doi: 10.3390/medicina60101676
  112. Kashif A, Chekera M, Malakasis A, Sarli V, Machairiotis N. Mediterranean diet as a management strategy for gestational diabetes mellitus: a narrative review of the literature. Cureus. 2025;17(1):e76906. doi: 10.7759/cureus.76906
  113. Rasmussen L, Knorr S, Antoniussen CS, et al. The impact of lifestyle, diet and physical activity on epigenetic changes in the offspring—a systematic review. Nutrients. 2021;13(8):2821. doi: 10.3390/nu13082821
  114. Krishnaveni GV, Hill JC, Veena SR, et al. Low plasma vitamin B12 in pregnancy is associated with gestational ‘diabesity’ and later diabetes. Diabetologia. 2009;52(11):2350-2358. doi: 10.1007/s00125-009-1499-0
  115. Sukumar N, Rafnsson SB, Kandala NB, Bhopal R, Yajnik CS, Saravanan P. Prevalence of vitamin B-12 insufficiency during pregnancy and its effect on offspring birth weight: a systematic review and meta-analysis. Am J Clin Nutr. 2016;103(5):1232-1251. doi: 10.3945/ajcn.115.123083
  116. Gernand AD, Schulze KJ, Stewart CP, West KP Jr, Christian P. Micronutrient deficiencies in pregnancy worldwide: health effects and prevention. Nat Rev Endocrinol. 2016;12(5):274- 289. doi: 10.1038/nrendo.2016.37
  117. Rogne T, Tielemans MJ, Chong MFF, et al. Associations of maternal vitamin B12 concentration in pregnancy with the risks of preterm birth and low birth weight: a systematic review and meta-analysis of individual participant data. Am J Epidemiol. 2017;185(3):212-223. doi: 10.1093/aje/kww212
  118. Kalra B, Kalra S, Sharma JB. The inositols and polycystic ovary syndrome. Indian J Endocrinol Metab. 2016;20(5):720- 724. doi: 10.4103/2230-8210.189231
  119. Palomba S, Falbo A, La Sala GB. Clomiphene citrate, metformin or aromatase inhibitors for anovulatory infertility in women with polycystic ovary syndrome (PCOS): a systematic review of meta-analyses and randomized controlled trials. Clin Immunol Endocr Metab Drugs. 2014;1(1):2-10. doi: 10.2174/22127070114019990001
Share
Back to top
Journal of Clinical and Translational Research, Electronic ISSN: 2424-810X Print ISSN: 2382-6533, Published by AccScience Publishing